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Toxoplasma gondii, the causative agent of toxoplasmosis, is an intracellular parasite that demonstrates a
remarkable ability to adapt to nutrient availability. In this issue of Cell Host & Microbe, Blume et al. (2015)
describe the unique role of a gluconeogenic enzyme in regulation of glucose catabolism in T. gondii.Like all organisms, pathogenic microbes
must adapt to dynamic environmental
conditions. In particular, access to and
utilization of carbon sources must be
adjusted in the face of excess or starva-
tion. Microorganisms have developed
elegant sensory systems to recognize
environmental conditions and adapt
accordingly. Understanding microbial
metabolism has implications for patho-
genesis, drug development, and drug
resistance.
Canonical nutrient sensory systems
involve detecting extracellular small mole-
cules via specific receptors, which then
direct cellular metabolism via down-
stream signaling pathways. Recently, a
more ‘‘introspective’’ mechanism has
been described, in which microbial cells
carefully monitor their own metabolic
flux and adjust metabolism accordingly.
For example, such a pathway has been
described for the Gram-negative bacte-
rium Escherichia coli, which surveys
glycolytic flux through fructose 1,6-bi-
sphosphate (FBP), a metabolic intermedi-
ate of both glycolysis (glucose break-
down) and gluconeogenesis (glucose
synthesis). In E. coli, FBP levels function
to indicate glycolytic flux and are influ-
enced by the activity of downstream
glycolytic enzymes. As the ability of FBP
to sense flux is independent of carbon
source, this elegant solution allows the
bacterium to carefully monitor its meta-
bolism via an integrated sensor, regard-
less of environmental conditions (Kocha-
nowski et al., 2013). Studies such as
these suggest that other metabolites
may serve as intracellular cues that direct
metabolic flux.
Intracellular pathogens, such as the
Apicomplexan parasite Toxoplasma gon-142 Cell Host & Microbe 18, August 12, 2015dii, provide a unique context to under-
stand these kinds of adaptations.
T. gondii tachyzoites are capable of in-
fecting almost any nucleated cell type. In
these varied niches, T. gondii prefers to
use glucose as a carbon source for ATP
generation and various anabolic reac-
tions. However, the parasite is also able
to utilize the amino acid glutamine as a
carbon source when glucose is limited
(Blume et al., 2009; MacRae et al.,
2012). In this case, the parasite must syn-
thesize glucose through gluconeogen-
esis. A key enzyme in this pathway is
fructose 1,6-bisphosphatase (FBPase),
which catalyzes the conversion of FBP
to fructose 6-phosphate. As expected,
most microbes repress expression of
gluconeogenic enzymes such as FBPase
during normal growth, when glucose is
abundant. Blume and colleagues investi-
gate an intriguing exception to this
rule: T. gondii constitutively expresses
FBPases during growth in a glucose-
replete environment (Blume et al., 2015).
This observation raises the question of
how these enzymes may function during
glucose catabolism, especially in a para-
site that successfully inhabits so many
environments. Why would the parasite
waste carbon and energy to make
glucose when it already has it?
Blume et al. (2015) tackle this question
using a thorough suite of genetically
manipulated T. gondii strains and 13C la-
beling experiments. They find that the
FBPase TgFBP2 is responsible for the
majority of gluconeogenic flux, and
intriguingly, TgFBP2 is required for para-
site growth evenwhen glucose is plentiful.
Consequently, TgFBP2 is also required
for acute virulence in mouse infections.
This points to a novel role for this enzymeª2015 Elsevier Inc.and for ‘‘futile metabolic cycles’’ in micro-
bial metabolism.
Blume et al. (2015) investigated the
metabolic consequences of TgFBP2
knockdown to understand how TgFBP2
is directing flux (Figure 1). They observe
an increase in lactate production, as
well as a decrease in TCA cycle interme-
diates and apicoplast (plastid organelle)-
derived fatty acids, all of which are pro-
duced from glycolytic intermediates.
These findings suggest that, in the
absence of TgFBP2, the glycolytic prod-
uct pyruvate is directed toward lactate
production instead of aerobic respiration.
Knockdown of TgFBP2 also results in
reduced levels of sugar nucleotide and
glycosylation. TgFBP2 thus appears to
direct flux at a canonically important
regulation step of central carbon meta-
bolism: the interconversion of fructose
6-phosphate and FBP. Like E. coli,
T. gondii centers this regulation on the
metabolite FBP. The parasite simulta-
neously co-expresses the FBP-utilizing
enzyme TgFBP2 alongside FBP-gener-
ating enzymes, such as the canonical
glycolytic regulator phosphofructokinase.
This co-expression of opposing meta-
bolic pathways begs the question: How
does the cell fine-tune the activity of
TgFBP2 and glycolytic enzymes under
changing nutrient conditions? Blume
et al. (2015) suggest that, as in E. coli, a
transcriptional response is at least
partially responsible in T. gondii. Parasites
deficient in glucose transport upregulate
TgFBP2 expression. However, it remains
unknown what cellular sensor drives this
change in mRNA levels. Perhaps the
metabolite FBP functions as this signal,
as in E. coli. In the case of T. gondii, glyco-
lytic and gluconeogenic enzymes are
Figure 1. Schematic of Metabolic Regulation by TgFBP2
TgFBP2 participates in gluconeogenesis (glucose synthesis), the reverse of
glycolysis (glucose breakdown). TgFBP2 is co-expressed alongside glycolytic
enzymes, such as phosphofructokinase (PFK), and is required for growth, even
in glucose-rich conditions. This points to a novel role for TgFBP2 as a meta-
bolic regulator, allowing the cell to ‘‘fine-tune’’ its metabolism and direct meta-
bolic flux. Metabolic consequences of TgFBP2 knockdown include increased
lactate production and a decrease in TCA cycle intermediates.
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Previewsco-expressed, even in
glucose-rich conditions. This
suggests that this ‘‘tuning’’ of
glycolysis versus gluconeo-
gensis happens post-transla-
tionally, or at the enzymatic
level through allosteric
regulation.
This novel mechanism of
metabolic regulation may
highlight pointsof vulnerability
as well as resistance in patho-
genic microbes such as
T. gondii. Blume et al. estab-
lish the essentiality of
TgFBP2. Thus, TgFBP2 may
represent a potential drug
target for T. gondii infection.
Toxoplasma FBPases are
similar to bacterial FBPases
(Teich et al., 2007) and have
allosteric regulation distinct
from eukaryotic (host)
FBPases, suggesting that mi-
crobial FBPases may be
selectively targeted (Gao
et al., 2014;Hines et al., 2007).
This discovery of ‘‘futile
cycling’’ as a novel mecha-
nism of metabolic regulationimpacts our understanding of how mi-
crobes adapt to metabolic stresses,
such as those imposed by drug treat-
ment. These regulation steps may point
to novel mechanisms of drug resistance.
Previously uncharacterized metabolic
regulators have been shown to confer
differential sensitivity to antiparasitics inthe malaria parasite Plasmodium falcipa-
rum (Guggisberg et al., 2014). A number
of antiparasitics target or impact various
aspects of parasite metabolism (Cobbold
et al., 2015). Just as the essential nature
of TgFBP2 was unanticipated, we can
predict that the metabolic stresses
from these antimicrobial therapies willCell Host & Microbe 18, August 12,ultimately uncover addi-
tional, unexpected adaptive
strategies.
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